Shijin Liu Yiran Zhang Yujian Lin Peize Wang Yunlong Pan
10.3389/fimmu.2022.981527
Front Immunol
2022 Sep 2;13:981527.
mss/msi-l/p-mmr sbrt advanced rectal cancer immunotherapy liver metastasis
CC BY
https://pubmed.ncbi.nlm.nih.gov/36119063/
Colorectal Neoplasms / drug therapy Colorectal Neoplasms / therapy Liver Neoplasms / genetics Liver Neoplasms / therapy Radiosurgery Rectal Neoplasms / genetics Rectal Neoplasms / therapy
Colorectal Neoplasms / drug therapy Colorectal Neoplasms / therapy Liver Neoplasms / genetics Liver Neoplasms / therapy Radiosurgery Rectal Neoplasms / genetics Rectal Neoplasms / therapy Case Reports Research Support, Non-U.S. Gov't B7-H1 Antigen Biomarkers, Tumor Carbohydrates Carcinoembryonic Antigen DNA Mismatch Repair Humans Immunotherapy / methods Microsatellite Instability B7-H1 Antigen Biomarkers, Tumor Carbohydrates Carcinoembryonic Antigen
PMC9479073
36119063
Case report: The MSI-L/p-MMR metastatic rectal cancer patient who failed systemic therapy responds to anti-PD-1 immunotherapy after stereotactic body radiation-therapy
2022